Polygenic risk scores to predict cardiovascular and renal complications

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00085714" target="_blank" >RIV/00023001:_____/25:00085714 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Polygenic risk scores to predict cardiovascular and renal complications

Popis výsledku v původním jazyce

The seminar focused on genetic approaches to predicting the complications of type 1 and type 2 diabetes. The event was divided into three sections:1.Polygenic risk scores for predicting cardiovascular and renal complications in patients with type 2 diabetes.The seminar&apos;s keynote lecture presented the concept of polygenic risk scores and their application in predicting these complications. The results of the latest research were presented and the practical applications of these findings in clinical practice were discussed.2.Introduction and clinical characteristics of the CORDIA studyThis section provided a description of the clinical characteristics of CORDIA study participants, with an emphasis on the phenotype groups that IKEM has in the DT1 cohort.3.The GENOCORDIA study and new directionsA presentation of the GENOCORDIA study, including the plan for identifying genetic markers of type 1 diabetes and its complications, as well as new research directions and future perspectives in this field.

Název v anglickém jazyce

Polygenic risk scores to predict cardiovascular and renal complications

Popis výsledku anglicky

The seminar focused on genetic approaches to predicting the complications of type 1 and type 2 diabetes. The event was divided into three sections:1.Polygenic risk scores for predicting cardiovascular and renal complications in patients with type 2 diabetes.The seminar&apos;s keynote lecture presented the concept of polygenic risk scores and their application in predicting these complications. The results of the latest research were presented and the practical applications of these findings in clinical practice were discussed.2.Introduction and clinical characteristics of the CORDIA studyThis section provided a description of the clinical characteristics of CORDIA study participants, with an emphasis on the phenotype groups that IKEM has in the DT1 cohort.3.The GENOCORDIA study and new directionsA presentation of the GENOCORDIA study, including the plan for identifying genetic markers of type 1 diabetes and its complications, as well as new research directions and future perspectives in this field.

Druh

M - Uspořádání konference

CEP obor

—

OECD FORD obor

30202 - Endocrinology and metabolism (including diabetes, hormones)

Projekt

<a href="/cs/project/LX22NPO5104" target="_blank" >LX22NPO5104: Národní institut pro výzkum metabolických a kardiovaskulárních onemocnění</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Místo konání akce

Praha

Stát konání akce

CZ - Česká republika

Datum zahájení akce

—

Datum ukončení akce

—

Celkový počet účastníků

30

Počet zahraničních účastníků

—

Typ akce podle státní přísl. účastníků

CST - Celostátní akce